Navigation Links
WuXi AppTec and QIAGEN Enter into Partnership Agreement for Molecular Biomarker Development
Date:1/10/2010

leader in providing integrated research and development services to the pharmaceutical industry," said Dr. Victor Shi, President, Asia Pacific of QIAGEN. "In doing so, we have created what we believe to be the first laboratory of its kind in Asia equipped with a standardized, fully integrated, automated sample and assay technology platform for drug discovery and development and molecular diagnostics in personalized healthcare and other areas. We believe that this partnership is a significant milestone in providing high-quality and complete automated solutions for the molecular biomarker testing industry."

About WuXi AppTec:

WuXi AppTec is a leading pharmaceutical, biotechnology, and medical-device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi AppTec provides a broad and integrated portfolio of laboratory and manufacturing services throughout the pharmaceutical and medical-device R&D process. WuXi AppTec's services are designed to help its global partners to improve the success, shorten the time, and reduce the cost of research and development.

Web: http://www.wuxiapptec.com .

About QIAGEN:

QIAGEN N.V., a Netherlands holding company, is the leading global provider of sample and assay technologies. Sample technologies are used to isolate and process DNA, RNA, and proteins from biological samples such as blood or tissue. Assay technologies are used to make such isolated bio-molecules visible. QIAGEN has developed and markets more than 500 sample and assay products as well as automated solutions for such consumables. The company provides its products to molecular diagnostics laboratorie
'/>"/>

SOURCE WuXi AppTec Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Ending Cervical Cancer Featured at Summit; QIAGEN CEO Issues a Call to Global Women Leaders
2. Study Finds QIAGENs HPV Test Offers Greater Long-term Protection From Cervical Disease Than the Pap
3. Webcast of QIAGEN N.V.s (Nasdaq: QGEN) First Quarter 2008 Financial Results Call Set for May 6
4. QIAGEN and Center for Molecular Medicine Create Research Collaboration for Molecular Diagnostic Markers for Breast Cancer, Other Womens Health Issues
5. QIAGEN N.V. (Nasdaq: QGEN) Invites You to Join Its Third Quarter 2007 Earnings Conference Call on the Web
6. University of Pittsburgh Medical Center (UPMC) Treats 10,000th Patient with Leksell Gamma Knife Radiosurgery System
7. Baylor Adds Naviscan PEM Technology to Womens Imaging Center
8. Soligenix Announces Initiation of a Phase 1/2 Clinical Trial of SGX201 for the Prevention of Acute Radiation Enteritis
9. Ambit Biosciences and Astellas Enter Strategic Partnership to Research, Develop and Commercialize FLT3 Kinase Inhibitors in Multiple Indications
10. Fenwal Responds to New Lawsuit From Haemonetics; Reiterates Commitment to Blood Centers
11. Rib-X Pharmaceuticals Enters into Collaborative Agreement on Delafloxacin with Massachusetts General Hospital
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... , June 30, 2015 Dipexium ... stage pharmaceutical company focused on the development and ... the closing of its previously announced underwritten public ... underwriters also exercised their over-allotment option in full ... stock. The net proceeds to Dipexium ...
(Date:6/30/2015)... 30, 2015 Pulse Light Clinic in ... to Rosacea sufferers as part of their ongoing research into ... found effective for their Rosacea. The survey participants were aged ... men and 53% women. The results revealed some ... not consider or attempt to visit their GP for Rosacea ...
(Date:6/30/2015)... -- Ardelyx, Inc. (NASDAQ: ARDX ), a clinical-stage biopharmaceutical ... announced that the Company will host its inaugural R&D ... pm EDT in New York City ... will present an overview of the Company,s pipeline programs, ... 2b clinical trials for the treatment of patients with ...
Breaking Medicine Technology:Dipexium Announces Closing of Public Offering of Common Stock 2Dipexium Announces Closing of Public Offering of Common Stock 384% of Rosacea Sufferers Say NHS Treatments Were "Ineffective" New Survey Reveals 284% of Rosacea Sufferers Say NHS Treatments Were "Ineffective" New Survey Reveals 3Ardelyx to Host Inaugural R&D Investor Day in New York City on July 14, 2015 2
... , DENVER , Feb. 11 ... and marketer of diagnostic test kits, today filed its 2nd quarter ... the company,s revenues slightly declined during the quarter but slightly increased ... of the results highlighted by the report are as follows: , ...
... MOUNTAIN VIEW, Calif. , Feb. 11 Alexza Pharmaceuticals, ... & Drug Administration has accepted the AZ-004 NDA for filing and ... of October 11, 2010 .  Alexza filed the AZ-004 NDA ... for the rapid treatment of agitation in patients with schizophrenia or ...
Cached Medicine Technology:Corgenix Reports Second Quarter Fiscal 2010 Financial Results 2Corgenix Reports Second Quarter Fiscal 2010 Financial Results 3Corgenix Reports Second Quarter Fiscal 2010 Financial Results 4Alexza Announces AZ-004 (Staccato(R) Loxapine) PDUFA Goal Date of October 11, 2010 2Alexza Announces AZ-004 (Staccato(R) Loxapine) PDUFA Goal Date of October 11, 2010 3
(Date:6/30/2015)... ... June 30, 2015 , ... In ... heart attack and stroke incidents are linked to testosterone replacement therapy announce an ... Conference is scheduled for July 9, 2015, according to court documents.* The testosterone ...
(Date:6/30/2015)... ... June 30, 2015 , ... The ... (D-MA) and Danny Davis (D-IL) for writing to the Department of Health and ... nation’s largest behavioral healthcare system, Universal Health Services (UHS).[1] CCHR is expanding its ...
(Date:6/30/2015)... ... June 30, 2015 , ... India Network Foundation ... Aetna, Inc. for its visitor health insurance plans that provides coverage for visitors to ... providers nationwide to enable visitors to obtain services from most experienced health care professional ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... D. Wagner, Chief Research and Strategy Officer at Predictive Analytics Reporting (PAR) Framework, ... National Science Foundation (NSF), will provide keynote addresses at the 2015 STEMtech conference ...
(Date:6/30/2015)... ... June 30, 2015 , ... Under ... protection at less thickness than any other padding in football. , Developed in ... and shock absorption, Gameday Armour is engineered with D3O protective polymer. This radical ...
Breaking Medicine News(10 mins):Health News:Testosterone Lawsuit News: July Conference on Bellweather Trials 2Health News:Testosterone Lawsuit News: July Conference on Bellweather Trials 3Health News:Testosterone Lawsuit News: July Conference on Bellweather Trials 4Health News:CCHR Seeks Public Input on Psychotropic Drug Billing and Psychiatric Abuse: Applauds Congressmen for Behavioral Hospitals Investigation Call 2Health News:CCHR Seeks Public Input on Psychotropic Drug Billing and Psychiatric Abuse: Applauds Congressmen for Behavioral Hospitals Investigation Call 3Health News:CCHR Seeks Public Input on Psychotropic Drug Billing and Psychiatric Abuse: Applauds Congressmen for Behavioral Hospitals Investigation Call 4Health News:CCHR Seeks Public Input on Psychotropic Drug Billing and Psychiatric Abuse: Applauds Congressmen for Behavioral Hospitals Investigation Call 5Health News:India Network Announces Accessibility of First Health PPO Nationwide Network for Visitor Health Insurance Plan Participants Effective July 1, 2015 2Health News:India Network Announces Accessibility of First Health PPO Nationwide Network for Visitor Health Insurance Plan Participants Effective July 1, 2015 3Health News:League for Innovation Announces Distinguished Keynote Presenters for STEMtech Conference 2Health News:League for Innovation Announces Distinguished Keynote Presenters for STEMtech Conference 3Health News:Under Armour Launches Advanced Gameday Armour® Max Protection System For The Gridiron 2
... Ranbaxy Laboratories and Cipla announced an alliance to ... had recently received Drug Controller General of India’s ... a unique dosage form of the broad-spectrum antibiotic. ... be around Rs 310 crore. //,Ciprofloxacin ...
... antioxidants, often as compounds known as flavonoids. It has ... levels of health-promoting flavonoids than apples or orange juice. ... are produced when oxygen burns glucose in cells to ... like DNA and proteins, setting the scene for heart ...
... There are many grueling and expensive options to explore for ... being Acupuncture. ,According to an article from the San ... may have been through the other options. They usually face ... born with a certain number of eggs, hundreds are lost ...
... fruits and vegetables, but don't forget whole grains, if ... disease and cancer, researchers say. Fruits and vegetables especially ... risk by about 32%. , According to a study ... of two to three slices of whole-grain bread each day were ...
... can keep lungs from deteriorating and reduce the risk ... of Ohahio, Dr.Margit Pelkon and collegues investigated the effects ... Finnish participants in four groups:// those who had never ... quit intermittently, and those who had never quit. ...
... the US suggest that acupuncture is at least as ... evidence on the safety of complementary and alternative medicine(CAM). ... of the first serious safety assessments on acupuncture. In ... agreed to record any adverse events occurring between June ...
Cached Medicine News:
The Soft-Touch Timeter® Flowmeter is durable, long-lasting and easy to maintain. Timeter ® by Allied Flowmeters: Quality Plus Value....
... Amvex offers a complete line ... heliox and CO 2 . They ... of calibrations to best suit your ... dials specific to the gas in ...
... Amvex offers a complete line ... heliox and CO 2 . They ... of calibrations to best suit your ... dials specific to the gas in ...
... Amvex offers a complete line of flowmeters, available ... are all available in a variety of calibrations to ... dials specific to the gas in use, the Amvex ... colors replace the U with I. For Power Take-Off ...
Medicine Products: